We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

High-Throughput T Cell Profiling Technique Developed

By LabMedica International staff writers
Posted on 13 May 2020
Print article
Image: Linking peptide specificities with T cell transcriptomes (Photo courtesy of University of California, Santa Cruz).
Image: Linking peptide specificities with T cell transcriptomes (Photo courtesy of University of California, Santa Cruz).
T cells recognize foreign or aberrant antigens presented by major histocompatibility complex (MHC-I) expressing cells through the T cell receptor (TCR) and is the first critical step towards establishment of protective immunity against viruses and tumors.

Staining with multivalent MHC class-I reagents (multimers) followed by flow cytometry is routinely used to interrogate T cell responses, to characterize antigen-specific TCR repertoires and to identify immunodominant clones. Fluorescently tagged multimers displaying individual peptides of interest have revolutionized detection of antigen specific T cells.

A team of scientists working with those at the University of California, Santa Cruz (Santa Cruz, CA, USA) have has developed an approach for high-throughput T cell profiling. The key advance is the ability to load peptides of interest on the MHC proteins that the body uses to present foreign antigens to the immune system. These MHC proteins display these antigens on the surface of cells, activating the body's T cell response, through which the immune system kills malfunctioning or infected cells.

The ability to express antigens in high-throughput fashion would be a boon for immunologists as it could, for instance, allow them to more rapidly and comprehensively profile patient responses to antigens linked to cancer or different infectious diseases. In the case of SARS-CoV-2, for example, the scientist could load MHC proteins with peptides comprising the full complement of the virus' proteins and look at which peptides were most important in prompting the T cell response or how T cell repertoires varied depending on the severity of infection or patient outcome.

To address unbound MHC, the team developed an approach using the protein TAPasin Binding Protein Related (TAPBPR), a chaperone protein that binds to MHCs to maintain their stability and also facilitates the exchange of peptides bound to the MHC. The process was streamlined somewhat by use of a workflow that produced MHCs bound to standard placeholder peptides instead of the particular peptide of interest, which allowed the team to produce MHC-antigen peptide complexes in bulk. The placeholder peptides were bound to the MHC via a photosensitive bond that could be disrupted by applying UV light, allowing the investigators to remove the placeholders and replace them with the actual peptides of interest when it was time to perform T cell profiling. The study was published on April 20, 2020 in the journal Nature Communications.

Related Links:
University of California, Santa Cruz

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.